Want to join the conversation?
$HSY 2Q15 Q&A: Matthew, Morgan Stanley: Any guidance on margin profile of International & Other businesses? JP, CEO: We’re always gross margin focused. We want to deepen our distribution coverage, but at the same time, we will also dictate how we activate our brands from a DME standpoint, et cetera. Those are some things that you’ll continue to see
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.